Sonelokimab (Anti-IL-17 & IL-17F & Serum Albumin)
Selected Variant
C00872
Size: 1 mg
Product Specifications
CAS Number
1414386-05-2
Synonyms
IL17MS3086, ALX-0761, M1095
SKU
C00872-1mg
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Sonelokimab is a humanized trivalent nanobody consisting of monovalent camelid-derived nanobodies that target human interleukin (IL) -17A, IL-17F, and human serum albumin. It exhibits clinical efficacy and dose-dependent modulation of psoriasis-associated genes in patients with plaque-type psoriasis. MW: 40.93 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A01568-1-HRP 100 µg/Vial
Anti-Protein S/PROS1 Antibody Picoband® (HRP Conjugate)
Sign In for Pricing
View Details 
BNC472889-100 1x 100 µL
Secretory Component / ECM1 (ECM1/2889R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUM2221-50 1x 50 µL
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/782), 1mg/mL
Sign In for Pricing
View Details 